{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:23:20Z","timestamp":1777688600084,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-3","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T18:02:05Z","timestamp":1388685725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatisinfections"],"prefix":"10.1186","volume":"14","author":[{"given":"Stephan P","family":"Verweij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esm\u00e9e","family":"Lanjouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J","family":"Bax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen D","family":"Quint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M","family":"Oostvogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P Joep","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolein","family":"Pleijster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry JC","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco PH","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander","family":"Ouburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Servaas A","family":"Morr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"issue":"Suppl A","key":"2967_CR1","first-page":"107","volume":"42","author":"SA Morr\u00e9","year":"2006","unstructured":"Morr\u00e9 SA, Spaargaren J, Ossewaarde JM, Land JA, Bax CJ, Dorr PJ, Oostvogel PM, Vanrompay D, Savelkoul PH, Pannekoek Y, et al: Description of the ICTI consortium: an integrated approach to the study of Chlamydia trachomatis infection. Drugs Today (Barc ). 2006, 42 (Suppl A): 107-114.","journal-title":"Drugs Today (Barc )"},{"key":"2967_CR2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1128\/IAI.74.1.578-585.2006","volume":"74","author":"BW Brunelle","year":"2006","unstructured":"Brunelle BW, Sensabaugh GF: The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome. Infect Immun. 2006, 74: 578-585. 10.1128\/IAI.74.1.578-585.2006.","journal-title":"Infect Immun"},{"key":"2967_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1172\/JCI119182","volume":"99","author":"D Dean","year":"1997","unstructured":"Dean D, Millman K: Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. J Clin Invest. 1997, 99: 475-483. 10.1172\/JCI119182.","journal-title":"J Clin Invest"},{"key":"2967_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/JCM.36.2.345-351.1998","volume":"36","author":"SA Morr\u00e9","year":"1998","unstructured":"Morr\u00e9 SA, Ossewaarde JM, Lan J, van Doornum GJ, Walboomers JM, MacLaren DM, Meijer CJ, van den Brule AJ: Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J Clin Microbiol. 1998, 36: 345-351.","journal-title":"J Clin Microbiol"},{"key":"2967_CR5","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/JB.181.15.4469-4475.1999","volume":"181","author":"A Meijer","year":"1999","unstructured":"Meijer A, Morr\u00e9 SA, van den Brule AJ, Savelkoul PH, Ossewaarde JM: Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis. J Bacteriol. 1999, 181: 4469-4475.","journal-title":"J Bacteriol"},{"key":"2967_CR6","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1128\/JCM.36.10.3077-3078.1998","volume":"36","author":"SA Morr\u00e9","year":"1998","unstructured":"Morr\u00e9 SA, Moes R, van Valkengoed IG, Boeke JP, van Eijk JT, Meijer CJ, van den Brule AJ: Genotyping of Chlamydia trachomatis in urine specimens will facilitate large epidemiological studies. J Clin Microbiol. 1998, 36: 3077-3078.","journal-title":"J Clin Microbiol"},{"key":"2967_CR7","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1128\/JCM.42.7.2935-2939.2004","volume":"42","author":"M Molano","year":"2004","unstructured":"Molano M, Meijer CJ, Morr\u00e9 SA, Pol R, van den Brule AJ: Combination of PCR targeting the VD2 of omp1 and reverse line blot analysis for typing of urogenital Chlamydia trachomatis serovars in cervical scrape specimens. J Clin Microbiol. 2004, 42: 2935-2939. 10.1128\/JCM.42.7.2935-2939.2004.","journal-title":"J Clin Microbiol"},{"key":"2967_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2353\/jmoldx.2007.070011","volume":"9","author":"KD Quint","year":"2007","unstructured":"Quint KD, van Doorn LJ, Kleter B, de Koning MN, van den Munckhof HA, Morr\u00e9 SA, ter Harmsel B, Weiderpass E, Harbers G, Melchers WJ, et al: A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars. J Mol Diagn. 2007, 9: 631-638. 10.2353\/jmoldx.2007.070011.","journal-title":"J Mol Diagn"},{"key":"2967_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/QCO.0b013e328320a8ae","volume":"22","author":"JA White","year":"2009","unstructured":"White JA: Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis. 2009, 22: 57-66. 10.1097\/QCO.0b013e328320a8ae.","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 2","key":"2967_CR10","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1086\/652398","volume":"201","author":"GI Byrne","year":"2010","unstructured":"Byrne GI: Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis. 2010, 201 (Suppl 2): S126-S133.","journal-title":"J Infect Dis"},{"key":"2967_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1086\/516291","volume":"26","author":"YT van Duynhoven","year":"1998","unstructured":"van Duynhoven YT, Ossewaarde JM, Derksen-Nawrocki RP, van der Meijden WI, van de Laar MJ: Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients\u2019 characteristics. Clin Infect Dis. 1998, 26: 314-322. 10.1086\/516291.","journal-title":"Clin Infect Dis"},{"key":"2967_CR12","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/JCM.38.6.2292-2296.2000","volume":"38","author":"SA Morr\u00e9","year":"2000","unstructured":"Morr\u00e9 SA, Rozendaal L, van Valkengoed IG, Boeke AJ, van Voorst Vader PC, Schirm J, de Blok S, van den Hoek JA, van Doornum GJ, Meijer CJ, et al: Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?. J Clin Microbiol. 2000, 38: 2292-2296.","journal-title":"J Clin Microbiol"},{"key":"2967_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/infdis\/172.2.589","volume":"172","author":"MF Lampe","year":"1995","unstructured":"Lampe MF, Wong KG, Stamm WE: Sequence conservation in the major outer membrane protein gene among Chlamydia trachomatis strains isolated from the upper and lower urogenital tract. J Infect Dis. 1995, 172: 589-592. 10.1093\/infdis\/172.2.589.","journal-title":"J Infect Dis"},{"key":"2967_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/clinids\/19.4.756","volume":"19","author":"KA Workowski","year":"1994","unstructured":"Workowski KA, Stevens CE, Suchland RJ, Holmes KK, Eschenbach DA, Pettinger MB, Stamm WE: Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis. 1994, 19: 756-760. 10.1093\/clinids\/19.4.756.","journal-title":"Clin Infect Dis"},{"key":"2967_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/jcp.2004.021543","volume":"58","author":"JM Lyons","year":"2005","unstructured":"Lyons JM, Ito JI, Pena AS, Morr\u00e9 SA: Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. J Clin Pathol. 2005, 58: 397-401. 10.1136\/jcp.2004.021543.","journal-title":"J Clin Pathol"},{"key":"2967_CR16","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/humrep\/deg347","volume":"18","author":"VA Akande","year":"2003","unstructured":"Akande VA, Hunt LP, Cahill DJ, Caul EO, Ford WC, Jenkins JM: Tubal damage in infertile women: prediction using chlamydia serology. Hum Reprod. 2003, 18: 1841-1847. 10.1093\/humrep\/deg347.","journal-title":"Hum Reprod"},{"issue":"Suppl B","key":"2967_CR17","first-page":"135","volume":"45","author":"SP Verweij","year":"2009","unstructured":"Verweij SP, Bax CJ, Quint KD, Quint WG, van Leeuwen AP, Peters RP, Oostvogel PM, Mutsaers JA, Dorr PJ, Pleijster J, et al: Significantly higher serologic responses of Chlamydia trachomatis B group serovars versus C and I serogroups. Drugs Today (Barc ). 2009, 45 (Suppl B): 135-140.","journal-title":"Drugs Today (Barc )"},{"key":"2967_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2334-5-114","volume":"5","author":"S Ouburg","year":"2005","unstructured":"Ouburg S, Spaargaren J, den Hartog JE, Land JA, Fennema JS, Pleijster J, Pena AS, Morr\u00e9 SA: The CD14 functional gene polymorphism -260C\u2009>\u2009T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology. BMC Infect Dis. 2005, 5: 114-10.1186\/1471-2334-5-114.","journal-title":"BMC Infect Dis"},{"key":"2967_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1017\/S0950268811001336","volume":"140","author":"A Haasnoot","year":"2012","unstructured":"Haasnoot A, Koedijk FD, Op de Coul ELM, Gotz HM, van der Sande MA, van den Broek IV: Comparing two definitions of ethnicity for identifying young persons at risk for chlamydia. Epidemiol Infect. 2012, 140: 951-958. 10.1017\/S0950268811001336.","journal-title":"Epidemiol Infect"},{"key":"2967_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/sti.2003.006395","volume":"80","author":"J Spaargaren","year":"2004","unstructured":"Spaargaren J, Verhaest I, Mooij S, Smit C, Fennema HS, Coutinho RA, Pe\u00f1a AS, Morr\u00e9 SA: Analysis of Chlamydia trachomatis serovar distribution changes in the Netherlands (1986\u20132002). Sex Transm Infect. 2004, 80: 151-152. 10.1136\/sti.2003.006395.","journal-title":"Sex Transm Infect"},{"key":"2967_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-0719-8","volume-title":"Chlamydia","author":"P-A Mardh","year":"1989","unstructured":"Mardh P-A, Paavonen J, Puolakkainen M: Chlamydia. 1989, New York: Plenum Medical Book Company"},{"key":"2967_CR22","unstructured":"Mann\u2013Whitney U Test. http:\/\/elegans.swmed.edu\/~leon\/stats\/utest.html,"},{"key":"2967_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1128\/JCM.40.2.584-587.2002","volume":"40","author":"SA Morr\u00e9","year":"2002","unstructured":"Morr\u00e9 SA, Munk C, Persson K, Kruger-Kjaer S, van Dijk R, Meijer CJ, van den Brule AJ: Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies. J Clin Microbiol. 2002, 40: 584-587. 10.1128\/JCM.40.2.584-587.2002.","journal-title":"J Clin Microbiol"},{"key":"2967_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/sextrans-2011-050386","volume":"89","author":"PJ Horner","year":"2013","unstructured":"Horner PJ, Wills GS, Reynolds R, Johnson AM, Muir DA, Winston A, Broadbent AJ, Parker D, McClure MO: Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study. Sex Transm Infect. 2013, 89: 398-403. 10.1136\/sextrans-2011-050386.","journal-title":"Sex Transm Infect"},{"key":"2967_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/humupd\/dmp035","volume":"16","author":"JA Land","year":"2010","unstructured":"Land JA, van Bergen JE, Morr\u00e9 SA, Postma MJ: Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update. 2010, 16: 189-204. 10.1093\/humupd\/dmp035.","journal-title":"Hum Reprod Update"},{"key":"2967_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.mcp.2010.04.007","volume":"24","author":"KD Quint","year":"2010","unstructured":"Quint KD, Bom RJ, Bruisten SM, van Doorn LJ, Nassir HN, Melchers WJ, de Vries HJ, Morr\u00e9 SA, Quint WG: Comparison of three genotyping methods to identify Chlamydia trachomatis genotypes in positive men and women. Mol Cell Probes. 2010, 24: 266-270. 10.1016\/j.mcp.2010.04.007.","journal-title":"Mol Cell Probes"},{"key":"2967_CR27","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/iai.58.6.2021-2023.1990","volume":"58","author":"JI Ito Jr","year":"1990","unstructured":"Ito JI, Lyons JM, Airo-Brown LP: Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun. 1990, 58: 2021-2023.","journal-title":"Infect Immun"},{"key":"2967_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/315738","volume":"182","author":"LO Eckert","year":"2000","unstructured":"Eckert LO, Suchland RJ, Hawes SE, Stamm WE: Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J Infect Dis. 2000, 182: 540-544. 10.1086\/315738.","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"2967_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1258\/095646202762226092","volume":"13","author":"SA Morr\u00e9","year":"2002","unstructured":"Morr\u00e9 SA, van den Brule AJ, Rozendaal L, Boeke AJ, Voorhorst FJ, de Blok S, Meijer CJ: The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS. 2002, 13 (Suppl 2): 12-18.","journal-title":"Int J STD AIDS"},{"key":"2967_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1086\/428287","volume":"191","author":"M Molano","year":"2005","unstructured":"Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, Ronderos M, Munoz N, van den Brule AJ: The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis. 2005, 191: 907-916. 10.1086\/428287.","journal-title":"J Infect Dis"},{"key":"2967_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/315778","volume":"182","author":"D Dean","year":"2000","unstructured":"Dean D, Suchland RJ, Stamm WE: Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis. 2000, 182: 909-916. 10.1086\/315778.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:41:05Z","timestamp":1630550465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]},"assertion":[{"value":"20 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}